92 related articles for article (PubMed ID: 3887108)
1. The pleiotropic properties of a beta-lactam antibiotic-hypersensitive mutant derived from Proteus vulgaris IFO 3167.
Hamakado T; Yoshida T; Kido Y; Miyagawa E; Motoki Y
Microbiol Immunol; 1985; 29(1):81-4. PubMed ID: 3887108
[No Abstract] [Full Text] [Related]
2. Inducer activity of beta-lactam antibiotics for the beta-lactamases of Proteus rettgeri and Proteus vulgaris.
Yotsuji A; Minami S; Araki Y; Inoue M; Mitsuhashi S
J Antibiot (Tokyo); 1982 Nov; 35(11):1590-3. PubMed ID: 6761329
[No Abstract] [Full Text] [Related]
3. Nature of monocyclic beta-lactam antibiotic Nocardicin A to beta-lactamases.
Kojo H; Mine Y; Nishida M; Goto S; Kuwahara S
Microbiol Immunol; 1988; 32(2):119-30. PubMed ID: 3287105
[TBL] [Abstract][Full Text] [Related]
4. Morphological mutants of Escherichia coli: nature of the permeability barrier in mon and envC cells.
Starkova Z; Thomas P; Starka J
Ann Microbiol (Paris); 1978 Apr; 129(3):265-84. PubMed ID: 352222
[TBL] [Abstract][Full Text] [Related]
5. PS-5, a new beta-lactam antibiotic. III. Synergistic effects and inhibitory activity against a beta-lactamase.
Okamura K; Sakamoto M; Fukagawa Y; Ishikura T; Lein J
J Antibiot (Tokyo); 1979 Apr; 32(4):280-6. PubMed ID: 381269
[TBL] [Abstract][Full Text] [Related]
6. [Resistance of clinical strains of Proteus to various beta-lactam antibiotics].
Shvidenko IG
Antibiotiki; 1976 Oct; 21(10):910-4. PubMed ID: 793508
[TBL] [Abstract][Full Text] [Related]
7. In vitro evaluation of SF-2103A, a novel carbapenem antibiotic, as a beta-lactamase inhibitor.
Niwa T; Yoshida T; Tamura A; Kazuno Y; Inouye S; Ito T; Kojima M
J Antibiot (Tokyo); 1986 Jul; 39(7):943-55. PubMed ID: 3019978
[TBL] [Abstract][Full Text] [Related]
8. Enterobacteria, beta-lactam antibiotics and beta-lactamases in clinical practice.
Newsom SW; Marshall MJ; Harris AM
J Med Microbiol; 1974 Nov; 7(4):473-82. PubMed ID: 4615152
[No Abstract] [Full Text] [Related]
9. Integrons, β-lactamase and qnr genes in multidrug resistant clinical isolates of Proteus mirabilis and P. vulgaris.
Mokracka J; Gruszczyńska B; Kaznowski A
APMIS; 2012 Dec; 120(12):950-8. PubMed ID: 23030307
[TBL] [Abstract][Full Text] [Related]
10. [Sensitivity to beta-lactam and aminoglycoside antibiotics of clinical Proteus strains as dependent upon on their species classification and the source of their isolation].
Shvidenko IG
Antibiot Med Biotekhnol; 1987 Nov; 32(11):850-5. PubMed ID: 3326520
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antimicrobial activity of highly functionalised novel β-lactam grafted spiropyrrolidines and pyrrolizidines.
Arumugam N; Periyasami G; Raghunathan R; Kamalraj S; Muthumary J
Eur J Med Chem; 2011 Feb; 46(2):600-7. PubMed ID: 21177001
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of the arn operon and loss of aminoarabinose on lipopolysaccharide as the cause of susceptibility to colistin in an atypical clinical isolate of proteus vulgaris.
Baron S; Leulmi Z; Villard C; Olaitan AO; Telke AA; Rolain JM
Int J Antimicrob Agents; 2018 Mar; 51(3):450-457. PubMed ID: 29203405
[TBL] [Abstract][Full Text] [Related]
13. PS-5 inhibition of a beta-lactamase from Proteus vulgaris.
Okamura K; Sakamoto M; Ishikura T
J Antibiot (Tokyo); 1980 Mar; 33(3):293-302. PubMed ID: 6991465
[TBL] [Abstract][Full Text] [Related]
14. [Antibiotic activity in relation to various Proteus species].
Kazanovskiĭ AM
Farm Zh; 1975; 30(3):79-83. PubMed ID: 767133
[No Abstract] [Full Text] [Related]
15. Formadicins, new monocyclic beta-lactam antibiotics of bacterial origin. I. Taxonomy, fermentation and biological activities.
Katayama N; Nozaki Y; Okonogi K; Ono H; Harada S; Okazaki H
J Antibiot (Tokyo); 1985 Sep; 38(9):1117-27. PubMed ID: 3934120
[TBL] [Abstract][Full Text] [Related]
16. [Tests of elimination of transferable antibiotic resistance. II. Treatment with anionic surface-active agents].
Rizzo G; Di Biase C
Ann Sclavo; 1972; 14(3):299-308. PubMed ID: 4592019
[No Abstract] [Full Text] [Related]
17. [Drug resistance of Proteus vulgaris, Proteus morganii and Providencia rettgeri isolated from diagnostic specimens].
Gołuszko P; Gospodarek E; Bugalski R
Przegl Epidemiol; 1987; 41(3):319-23. PubMed ID: 3324173
[No Abstract] [Full Text] [Related]
18. [Bactericidal activity of 5-chloro-8-hydroxy-7-iodoquinoline on various intestinal bacteria].
Stelzl G; Maier-Tenschert E
Arzneimittelforschung; 1973 Oct; 23(10):1470-3. PubMed ID: 4273090
[No Abstract] [Full Text] [Related]
19. [Antibiotic sensitivity of the H- and O-forms of bacteria in the genus Proteus].
Nesterova GN; Leont'eva AN; Savinova VM
Antibiotiki; 1978 Sep; 23(9):802-4. PubMed ID: 358911
[TBL] [Abstract][Full Text] [Related]
20. A Novel Non-Coding RNA CsiR Regulates the Ciprofloxacin Resistance in
Zhang H; Song T; Qin C; Xu H; Qiao M
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
